Lab-made ‘mild virus’ mimics coronavirus, can aid drug, vaccine discovery
Scientists have genetically modified a “mild virus” which generates antibodies in humans just like the novel coronavirus, but without causing severe disease, an advance which they say will enable more labs across the world to safely test drugs and vaccine candidates against COVID-19. The researchers from the Washington University School of Medicine in St Louis in the US engineered the […]
» Read more